Peptide-based supramolecular nanomaterials with super-large red-shifted absorption for antitumor therapy

studies revealed that the combined therapy markedly suppressed tumor growth and activated systemic antitumor immunity. These findings provide a robust nanomedicine candidate with enhanced stability, deep-tissue penetrability, and multimodal therapeutic synergy, paving the way for precision treatment of aggressive and deep-seated tumors.